Ella

— THERAPEUTIC CATEGORIES —
  • Contraception

Ella Generic Name & Formulations

General Description

Ulipristal acetate 30mg; tab.

Pharmacological Class

Progesterone agonist/antagonist.

How Supplied

Tab—1

Generic Availability

NO

Ella Indications

Indications

Prevention of pregnancy following unprotected intercourse or known or suspected contraceptive failure. Not for use as regular contraceptive.

Ella Dosage and Administration

Adult

Take 1 tab as soon as possible within 120hrs (5 days) after unprotected intercourse or contraceptive failure. May repeat dose if vomiting occurs within 3hrs.

Children

Premenarchal: not applicable.

Ella Contraindications

Contraindications

Known/suspected pregnancy.

Ella Boxed Warnings

Not Applicable

Ella Warnings/Precautions

Warnings/Precautions

Not for termination of an existing pregnancy. Exclude pregnancy before prescribing. Rule out ectopic pregnancy if lower abdominal pain occurs. Rule out pregnancy if subsequent menses delayed by >1 week. Does not protect against HIV or other STDs. Repeat use within same menstrual cycle: not recommended. Nursing mothers.

Ella Pharmacokinetics

See Literature

Ella Interactions

Interactions

Avoid concomitant CYP3A4 inducers (eg, barbiturates, bosentan, carbamazepine, felbamate, griseofulvin, oxcarbazepine, phenytoin, rifampin, topiramate, St. John's wort). Potentiated by CYP3A4 inhibitors (eg, ketoconazole, itraconazole). May affect or be affected by progestin-containing contraceptives; use reliable barrier method until next menstrual cycle and resume hormonal contraception ≥5 days after dose.

Ella Adverse Reactions

Adverse Reactions

Headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness; menstrual cycle changes.

Ella Clinical Trials

See Literature

Ella Note

Not Applicable

Ella Patient Counseling

See Literature